Merck & Co., Inc. (MRK)
Data as of September 4, 2026 · Drug Manufacturers - General
Stockbruh grade: Strong 5/5 metrics rated Sunny
What does Merck & Co., Inc. do?
🔬Merck & Co., Inc. is a global healthcare company headquartered in vibrant Kenilworth, New Jersey. They specialize in pharmaceutical and animal health, offering a range of products, from oncology and diabetes treatments to veterinary pharmaceuticals and vaccines. With collaborations galore, they're committed to developing cutting-edge solutions to keep us all healthy and thriving! 💊🐾.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ☀️ Strong | 5-year price performance |
| Profitability | ☀️ Strong | Net margin & return on equity |
| Growth | ☀️ Strong | Revenue & earnings trend |
| Earnings | ☀️ Strong | EPS vs analyst expectations |
| Cash & Debt | ☀️ Strong | Balance sheet strength |
| Price | $152.34 | Market Cap | — |
| Exchange | New York Stock Exchange | | |
Plain-English Analysis
What's it worth?
Based on 5-year performance trends, Merck & Co., Inc. has historically delivered strong returns. Sign up free for full valuation analysis including P/E, DCF estimates, and Stockbruh's plain-English take on whether this stock looks cheap or expensive right now.
Are they building the future?
Revenue and earnings are trending upward — Merck & Co., Inc. appears to be growing. Sign up free for the full growth analysis including year-over-year comparisons and R&D investment data.
What's ahead?
Recent earnings have been strong, meeting or beating analyst expectations. Sign up free for earnings history, EPS trends, and what analysts are forecasting next.